ZHONGSHENGYAOYE(SZ:002317) Xin Lang Cai Jing·2025-11-24 02:18Group 1 - The core viewpoint of the news is that Zhongsheng Pharmaceutical experienced a stock price increase of 5.3%, reaching 24.65 CNY per share, with a trading volume of 950 million CNY and a turnover rate of 5.18%, resulting in a total market capitalization of 20.951 billion CNY [1] - Zhongsheng Pharmaceutical, established on December 31, 2001, and listed on December 11, 2009, is primarily engaged in the research, production, and sales of pharmaceuticals. The revenue composition includes 53.03% from traditional Chinese medicine sales, 38.12% from chemical drug sales, 6.13% from Chinese medicinal materials and decoction pieces, 2.14% from raw materials and intermediates, and 0.58% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Jianxin Fund has a significant position in Zhongsheng Pharmaceutical. Jianxin High-end Medical Stock A (004683) held 403,600 shares in the third quarter, accounting for 5.61% of the fund's net value, making it the fifth-largest holding. The estimated floating profit today is approximately 500,500 CNY [2] - Jianxin High-end Medical Stock A (004683) was established on July 18, 2017, with a current scale of 121 million CNY. Year-to-date returns are 3.98%, ranking 3822 out of 4208 in its category, while the one-year loss is 4.18%, ranking 3823 out of 3981. Since inception, the fund has achieved a return of 42.26% [2]